Augmedix, Inc. Reiterates Earnings Guidance for the Second Quarter and Full Year of 2024
For the full year of 2024, management continues to expect revenue of approximately $52 to $55 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9166 USD | +0.94% |
|
-8.34% | -84.33% |
1st Jan change | Capi. | |
---|---|---|
-84.33% | 44.88M | |
+19.76% | 73.23B | |
+10.89% | 18.02B | |
+18.76% | 14.53B | |
+16.05% | 13.13B | |
+14.46% | 10.18B | |
-15.15% | 7.28B | |
-6.51% | 5.84B | |
+7.29% | 5.38B | |
+4.60% | 5.33B |